rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-12-23
|
pubmed:abstractText |
Our study compared use of atorvastatin, fluvastatin, lovastatin, and simvastatin for lowering low-density lipoprotein (LDL) cholesterol concentration in patients at risk for coronary heart disease (CHD). The goal was to reach the LDL cholesterol levels recommended by the National Cholesterol Education Program (NCEP).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0094-3509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
349-56
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9834769-Adult,
pubmed-meshheading:9834769-Aged,
pubmed-meshheading:9834769-Aged, 80 and over,
pubmed-meshheading:9834769-Anticholesteremic Agents,
pubmed-meshheading:9834769-Cholesterol, LDL,
pubmed-meshheading:9834769-Coronary Disease,
pubmed-meshheading:9834769-Female,
pubmed-meshheading:9834769-Heptanoic Acids,
pubmed-meshheading:9834769-Humans,
pubmed-meshheading:9834769-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:9834769-Male,
pubmed-meshheading:9834769-Middle Aged,
pubmed-meshheading:9834769-Practice Guidelines as Topic,
pubmed-meshheading:9834769-Prospective Studies,
pubmed-meshheading:9834769-Pyrroles,
pubmed-meshheading:9834769-Risk Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
|
pubmed:affiliation |
University of Minnesota, Minneapolis, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|